Abstract
Human mesenchymal stromal cells (MSCs) offer great hope for the treatment of tissue degenerative and immune diseases, but their phenotypic similarity to dermal fibroblasts may hinder robust cell identification and isolation from diverse tissue harvests. To identify genetic elements that can reliably discriminate MSCs from fibroblasts, we performed comparative gene and microRNA expression profiling analyses with genome-wide oligonucleotide microarrays. When taken globally, both gene and microRNA expression profiles of MSCs were highly similar to those of fibroblasts, accounting well for their extensive phenotypic and functional overlaps. Scattered expression differences were pooled to yield an MSC-specific molecular signature, consisting of 64 genes and 21 microRNAs whose expressions were at least 10-fold and two-fold higher, respectively, in MSCs compared with fibroblasts. Genes either encoding transmembrane proteins or associated with tumors were relatively abundant in this signature. These data should provide the molecular basis not only for the discovery of novel diagnostic markers discriminating MSCs from fibroblasts, but also for further studies on MSC-specific signaling mechanisms.
Similar content being viewed by others
References
Bao S, Ouyang G, Bai X, Huang Z, Ma C, Liu M, Shao R, Anderson AM, Rich JN, Wang XF (2004) Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway. Cancer Cell 5:329–339
Baskerville S, Barttel DP (2005) Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA 11:241–247
Brendel C, Kuklick L, Hartmann O, Kim TD, Boudriot U, Schwell D, Neubauer A (2005) Distinct gene expression profile of human mesenchymal stem cells in comparison to skin fibroblasts employing cDNA microarray analysis of 9600 genes. Gene Expr 12:245–257
Bushati N, Cohen SM (2007) MicroRNA functions. Annu Rev Cell Dev Biol 23:175–205
Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6:857–866
Chang HY, Chi JT, Dudoit S, Bondre C, Rijn M van de, Botstein D, Brown PO (2002) Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Sci Acad USA 99:12877–12882
Chen CZ, Li L, Lodish HF, Bartel DP (2004) MicroRNAs modulate hematopoietic lineage differentiation. Science 303:83–86
Cheng AM, Byrom MW, Shelton J, Ford LP (2005) Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 33:1290–1297
Darell DK, Kaur S, Stanislaw S, Konieczka JH, Yatskievych TA, Antin PB (2007) MicroRNA expression during chick embryo development. Dev Dyn 235:3156–3165
Dazzi F, Horwood NJ (2007) Potential of mesenchymal stem cell therapy. Curr Opin Oncol 19:650–655
Dominici M, Le Blanc JK, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop DJ, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315–317
Feldon SE, O’loughlin CW, Ray DM, Landskroner-Eiger S, Seweryniak KE, Phipps RP (2006) Activated human T lymphocytes express cyclooxygenase-2 and produce proadipogenic prostaglandins that drive human orbital fibroblasts differentiation to adipocytes. Am J Pathol 169:1183–1193
Fuchs B, Mahlum E, Halder C, Maran A, Yaszemski M, Bode B, Bolander M, Sarkar G (2007) High expression of tumor endothelial marker 7 is associated with metastasis and poor survival of patients with osteogenic sarcoma. Gene 399:137–143
Haniffa MA, Wang XN, Holtick U, Rae M, Isaacs JD, Dickinson AM, Hilkens CM, Collin MP (2007) Adult human fibroblasts are potent immunoregulatory cells and functionally equivalent to mesenchymal stem cells. J Immunol 179:1595–1604
Hee CK, Jonikas MA, Nicoll SB (2006) Influence of three-dimensional scaffold on the expression of osteogenic differentiation markers by human dermal fibroblasts. Biomaterials 27:875–884
Inoue T, Equchi T, Oda Y, Nishiyama K, Fujii K, Izumi H, Kohno K, Yamaquchi K, Tanaka M, Tsuneyoshi M (2007) Expression of GalNAc-T3 and its relationships with clinicopathological factors in 61 extrahepatic bile duct carcinomas analyzed using stepwise sections-special reference to its association with lymph node metastasis. Mod Pathol 20:267–276
Ishii M, Koike C, Igarashi A, Yamanaka K, Pan H, Higashi Y, Kawaguchi H, Sugiyama M, Kamata N, Iwata T, Matsubara T, Nakamura K, Kurihara H, Tsuji K, Kato Y (2005) Molecular markers distinguish bone marrow mesenchymal stem cells from fibroblasts. Biochem Biophys Res Comm 332:297–303
Javazon EH, Beggs KJ, Flake AW (2004) Mesenchymal stem cells: paradoxes of passaging. Exp Hematol 32:414–425
Jelaska A, Strehlow D, Korn JH (1999) Fibroblasts heterogeneity in physiological conditions and fibrotic diseases. Springer Semin Immunopathol 21:385–395
Jeong JA, Hong SH, Gang EJ, Ahn C, Hwang SH, Yang IH, Han H, Kim H (2005) Differential gene expression profiling of human umbilical cord blood-derived mesenchymal stem cells by DNA microarray. Stem Cells 23:584–593
Jeong JA, Ko KM, Bae S, Jeon CJ, Koh GY, Kim H (2007) Genome-wide differential gene expression profiling of human bone marrow stromal cells. Stem Cells 25:994–1002
Johansen JS, Brasso K, Iversen P, Teisner B, Garnero P, Price PA, Christensen IJ (2007) Changes of biochemical markers of bone turnover and YKL-40 following hormonal treatment for metastatic prostate cancer are related to survival. Clin Cancer Res 13:3244–3249
Keating A (2006) Mesenchymal stromal cells. Curr Opin Hematol 13:419–425
Kim VN, Nam JW (2006) Genomics of microRNA. Trend Genet 22:165–173
Le Blanc K, Pittenger MF (2005) Mesenchymal stem cells: progress toward promise. Cytotherapy 7:36–45
Liang Y, Ridzon D, Wong L, Chen C (2007) Characterization of microRNA expression profiles in normal human tissues. BMC Genomics 8:166
Lysy PA, Smets F, Sibille C, Najimi M, Sokal EM (2007) Human skin fibroblasts: from mesodermal to heptatocyte-like differentiation. Hepatol 46:1574–1585
Phillips JE, Hutmacher DW, Guldgerg RE, Garcia AJ (2006) Mineralization capacity of Runx2/Cbfa1-genetically engineered fibroblasts is scaffold dependent. Biomaterials 27:5535–5545
Rinn JL, Bondre C, Gladstone HB, Brown PO, Chang HY (2006) Anatomic demarcation by positional variation in fibroblast gene expression programs. PloS Genet 2:1084–1096
Rutherford RB, Gu K, Racenis P, Krebsbach PH (2003) Early events: the in vitro conversion of BMP transduced fibroblasts to chondroblasts. Connect Tissue Res 44:117–123
Sabatini F, Petecchia L, Tavian M, de Villeroche VJ, Rossi GA, Brouty-Boye D (2005) Human bronchial fibroblasts exhibit a mesenchymal stem cell phenotype and multilineage differentiating potentialities. Lab Invest 85:962–971
Silva Meirelles L da, Chagastelles PC, Nardi NB (2006) Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119:2204–2213
Sullivan CS, Ganem D (2005) MicroRNAs and viral infection. Mol Cell 20:3–7
Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, Bos PD, Gerald WL, Massague J (2008) Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451:147–152
Tocci A, Forte L (2003) Mesenchymal stem cell: use and perspectives. Hematol J 4:92–96
Author information
Authors and Affiliations
Corresponding author
Additional information
Sohyun Bae and Jung Hoon Ahn contributed equally to this work.
This research was supported in part by a grant (SC-2140) from Stem Cell Research Center of the 21st Century Frontier Research Program, and in part by Korea Science and Engineering Foundation grant (M10641000037) funded by the Ministry of Education, Science and Technology, Republic of Korea.
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
Supplementary Table 1
Gene expression signature of MSCs in comparison with fibroblasts (DOC 111 KB)
Supplementary Table 2
Hybridization intensity ratio of microRNAs (XLS 64 KB)
Rights and permissions
About this article
Cite this article
Bae, S., Ahn, J.H., Park, C.W. et al. Gene and microRNA expression signatures of human mesenchymal stromal cells in comparison to fibroblasts. Cell Tissue Res 335, 565–573 (2009). https://doi.org/10.1007/s00441-008-0729-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00441-008-0729-y